HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shan Lu Selected Research

barbourin

9/2005Inhibition of platelet aggregation of a mutant proinsulin chimera engineered by introduction of a native Lys-Gly-Asp-containing sequence.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shan Lu Research Topics

Disease

79Neoplasms (Cancer)
04/2022 - 03/2002
36Infections
01/2022 - 06/2005
30Prostatic Neoplasms (Prostate Cancer)
01/2022 - 03/2002
27Inflammation (Inflammations)
01/2022 - 07/2007
12Neoplasm Metastasis (Metastasis)
01/2022 - 06/2005
11Breast Neoplasms (Breast Cancer)
04/2022 - 06/2008
10Fibrosis (Cirrhosis)
07/2022 - 11/2016
10Glioma (Gliomas)
10/2021 - 01/2018
9Atherosclerosis
07/2022 - 01/2017
8Plague (Bubonic Plague)
12/2021 - 09/2004
7Hepatocellular Carcinoma (Hepatoma)
03/2022 - 03/2008
7Adenocarcinoma
01/2021 - 02/2006
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 01/2015
7Reperfusion Injury
01/2021 - 05/2016
7Human Influenza (Influenza)
08/2014 - 07/2008
6COVID-19
05/2022 - 01/2021
6Body Weight (Weight, Body)
01/2022 - 02/2014
5Disease Progression
08/2021 - 02/2015
5Lung Neoplasms (Lung Cancer)
01/2020 - 12/2011
5Virus Diseases (Viral Diseases)
01/2018 - 12/2006
5Ischemia
01/2018 - 06/2010
5Ovarian Neoplasms (Ovarian Cancer)
07/2016 - 08/2008
4Glioblastoma (Glioblastoma Multiforme)
05/2022 - 08/2015
4Thrombocytopenia (Thrombopenia)
03/2022 - 01/2018
4Carcinogenesis
03/2022 - 01/2014
4Communicable Diseases (Infectious Diseases)
01/2022 - 02/2005
4Hepatitis B
01/2022 - 05/2011
4Stomach Neoplasms (Stomach Cancer)
01/2021 - 01/2013
4Neurodegenerative Diseases (Neurodegenerative Disease)
01/2021 - 10/2006
4Myocardial Ischemia (Ischemic Heart Diseases)
01/2021 - 04/2018
4Type 2 Diabetes Mellitus (MODY)
03/2020 - 02/2014
4Bacterial Infections (Bacterial Infection)
01/2018 - 09/2011
3Non-alcoholic Fatty Liver Disease
07/2022 - 11/2020
3Liver Cirrhosis (Hepatic Cirrhosis)
07/2022 - 01/2021
3Liver Neoplasms (Liver Cancer)
03/2022 - 05/2018
3Pancreatic Neoplasms (Pancreatic Cancer)
03/2022 - 01/2019
3Leukopenia
03/2022 - 01/2021
3Diabetic Retinopathy (Retinopathy, Diabetic)
03/2021 - 01/2014
3Asthma (Bronchial Asthma)
01/2021 - 11/2012
3Wounds and Injuries (Trauma)
01/2021 - 12/2016
3Venous Thrombosis (Deep-Vein Thrombosis)
01/2021 - 11/2019
3Acute Kidney Injury (Acute Renal Failure)
10/2020 - 03/2018
3Lymphoma (Lymphomas)
04/2020 - 05/2016

Drug/Important Bio-Agent (IBA)

40Proteins (Proteins, Gene)FDA Link
05/2022 - 02/2005
31VaccinesIBA
06/2021 - 09/2004
24DNA (Deoxyribonucleic Acid)IBA
05/2022 - 10/2005
20Biomarkers (Surrogate Marker)IBA
03/2022 - 04/2009
19Pharmaceutical PreparationsIBA
03/2022 - 07/2007
16AntigensIBA
06/2021 - 09/2004
15CytokinesIBA
03/2022 - 06/2010
12Androgen Receptors (Androgen Receptor)IBA
01/2022 - 01/2006
12AntibodiesIBA
01/2022 - 03/2005
12MicroRNAs (MicroRNA)IBA
03/2021 - 07/2012
12Small Interfering RNA (siRNA)IBA
02/2021 - 06/2008
12DNA VaccinesIBA
01/2016 - 07/2006
9Biological ProductsIBA
03/2022 - 03/2005
9AndrogensIBA
01/2019 - 06/2005
8Therapeutic UsesIBA
07/2022 - 03/2018
7Interleukin-6 (Interleukin 6)IBA
03/2022 - 07/2007
7Neutralizing AntibodiesIBA
01/2022 - 06/2005
7Messenger RNA (mRNA)IBA
01/2022 - 12/2007
7LipidsIBA
01/2022 - 09/2012
7Long Noncoding RNAIBA
10/2021 - 01/2017
7Proliferating Cell Nuclear Antigen (PCNA)IBA
07/2021 - 12/2006
6Phospholipases (Phospholipase)IBA
06/2017 - 11/2010
5kushenIBA
03/2022 - 01/2021
5RNA (Ribonucleic Acid)IBA
03/2022 - 02/2016
5Phosphotransferases (Kinase)IBA
12/2021 - 05/2002
5Epidermal Growth Factor (EGF)IBA
12/2021 - 06/2008
5LigandsIBA
12/2021 - 08/2008
5Anti-Bacterial Agents (Antibiotics)IBA
09/2021 - 07/2006
5InterferonsIBA
01/2021 - 12/2006
5oxidized low density lipoproteinIBA
01/2020 - 01/2017
4IronIBA
01/2022 - 01/2018
4NF-kappa B (NF-kB)IBA
12/2021 - 08/2008
4Interleukin-10 (Interleukin 10)IBA
12/2021 - 07/2007
4AntioxidantsIBA
10/2021 - 01/2018
4p38 Mitogen-Activated Protein KinasesIBA
06/2021 - 07/2008
4Caspase 3 (Caspase-3)IBA
03/2019 - 01/2018
4ChromatinIBA
01/2019 - 06/2012
4EpitopesIBA
01/2018 - 03/2005
4Interleukin-8 (Interleukin 8)IBA
10/2009 - 06/2005
3Interleukin-17 (Interleukin 17)IBA
01/2022 - 04/2015
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 10/2007
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2021 - 07/2007
3Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
10/2021 - 07/2008
3JNK Mitogen-Activated Protein KinasesIBA
06/2021 - 05/2002
3Sirtuin 1IBA
02/2021 - 03/2019
3Blood Glucose (Blood Sugar)IBA
01/2021 - 01/2016
3InflammasomesIBA
01/2021 - 01/2020
3Indicators and Reagents (Reagents)IBA
01/2021 - 03/2012
3Competitive Endogenous RNAIBA
01/2021 - 01/2020

Therapy/Procedure

29Therapeutics
03/2022 - 01/2006
17Drug Therapy (Chemotherapy)
03/2022 - 08/2004
8Radiotherapy
01/2021 - 08/2004
6Immunotherapy
12/2021 - 09/2008
5Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2022 - 01/2018
4Precision Medicine
01/2021 - 04/2014
3Injections
10/2021 - 01/2021
3Ligation
01/2021 - 01/2012